Journal
/
/
Modeling Colitis-Associated Cancer with Azoxymethane (AOM) and Dextran Sulfate Sodium (DSS)
Journal JoVE
Médecine
Author Produced
Un abonnement à JoVE est nécessaire pour voir ce contenu.  Connectez-vous ou commencez votre essai gratuit.
Journal JoVE Médecine
Modeling Colitis-Associated Cancer with Azoxymethane (AOM) and Dextran Sulfate Sodium (DSS)
DOI:

12:37 min

September 11, 2012

, , ,

Chapitres

  • 00:05Titre
  • 01:26Colitis-associated Cancer Induction
  • 02:28Clinical Assessment of Colitis and Tumor Progression
  • 02:59Murine Endoscopy(Optional)
  • 04:24Mouse Sacrifice and Colon Harvesting
  • 06:55Preparing the Colon for Macroscopic Analysis
  • 07:55Preparing the Colon for Histological Assessment
  • 09:21Representative Results

Summary

Traduction automatique

We demonstrate a protocol in which administration of the genotoxic agent azoxymethane (AOM) followed by three cycles of the pro-inflammatory agent dextran sulfate sodium (DSS) rapidly and consistently generates colon tumors in mice with morphologic and molecular similarities to those seen in human colitis-associated cancer.

Vidéos Connexes

Read Article